Maya joined Gresham House in September 2019, and focuses on healthcare investments, including Orri, Metrion Biosciences and Panthera Biopartners.

Prior to Gresham House, she spent 4 years at Octopus Investments, investing in real estate-backed healthcare companies and entrepreneurs. Before this she worked at KPMG for 7 years in audit and corporate finance.

Maya holds a first-class degree in Modern History and is a Chartered Accountant (ICAEW).

Outside of work, Maya enjoys playing hockey (when not suffering from an injury!), travelling and watching martial arts films.

It’s a pleasure to be investing in the future of UK healthcare across a range of sub sectors and working with some of the country’s top scientists and clinicians to deliver world-class solutions.

Example portfolio

Shalin joined Gresham House in August 2022 and has 12 years’ financial experience.

I joined the Gresham House Ventures team because I enjoy the challenge of supporting courageous management to grow their businesses.

Prior to Gresham House, Shalin was a Portfolio Manager at BOOST&Co, turning around underperforming SME businesses. Shalin acted as a Non-Executive Director and observer on investments within various industries, including telecommunications, advertising technology, vehicle finance, smart metering logistics, and lead generation. Before this, he was an Equity Analyst at RMB Morgan Stanley.

Shalin holds a BCom (Hons) in Accounting Science.

Outside of work, he is a keen cricketer and passionate rugby fan. He also enjoys trying new recipes and frequently braai (South African-style BBQ) accompanied by a quality bottle of wine.

Example portfolio